Piper Sandler analyst Yasmeen Rahimi initiated coverage with a Buy rating on Bright Minds Biosciences (DRUG – Research Report) today and set a ...

Oppenheimer analyst Matthew Biegler says Blueprint Medicines (BPMC) reported Q4 Ayvakit sales of $146M, in line with consensus but below the ...

The litigation resulted from Teva submitting an Abbreviated New Drug Application to the U.S ... Axsome Reveals Data From Alzheimer’s Studies, Analyst Sees Hope Despite Mixed Trial Results ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug Entresto and newer multiple sclerosis drug Kesimpta exceeded forecasts.

The drug menace cannot be tackled by the NDLEA alone, as security concerns should be for all. We shall continue to appeal to ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

The Uttar Pradesh Subordinate Service Selection Commission (UPSSSC) has released the provisional answer key for the Junior Analyst Drugs Main exam (Advt. No. 05-Exam/2024) and Homeopathic ...

View all announcements for Akums Drugs and Pharmaceuticals Ltd Source: BSE India ...

Stifel analyst James Condulis writes Cytokinetics’ aficamten is an exceptional drug as it sets a strong competitive standard for a multi-billion-dollar obstructive hypertrophic cardiomyopathy ...